Cargando…

Adjunctive therapy for glucose control in patients with type 1 diabetes

Type 1 diabetes mellitus (T1DM) is characterized by relative or absolute insulin deficiency. Despite treatment with insulin therapy, glycemic goals are not always met, and insulin therapy is sometimes limited by adverse effects, including hypoglycemia and weight gain. Several adjunctive therapies ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Kira, Boland, Cassie, Meade, Lisa, Battise, Dawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927142/ https://www.ncbi.nlm.nih.gov/pubmed/29731652 http://dx.doi.org/10.2147/DMSO.S141700

Ejemplares similares

Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?
por: Warnes, Harriet, et al.
Publicado: (2018)

SGLT inhibitor adjunct therapy in type 1 diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2018)

Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
por: Ryan, Gina, et al.
Publicado: (2009)

The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
por: Raman, Vandana S., et al.
Publicado: (2010)

A review of exenatide as adjunctive therapy in patients with type 2 diabetes
por: Robles, Gisela I, et al.
Publicado: (2009)

Role of saxagliptin as monotherapy or adjunct therapy in the treatment of type 2 diabetes
por: Sharma, Morali D
Publicado: (2010)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
por: Odegard, Peggy Soule, et al.
Publicado: (2009)

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015)

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017)

Sodium‐glucose co‐transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials
por: Boeder, Schafer, et al.
Publicado: (2019)

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2015)

Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
por: Dejgaard, Thomas F., et al.
Publicado: (2021)

Adjunct Methods of the Standard Diabetic Foot Ulceration Therapy
por: Waniczek, Dariusz, et al.
Publicado: (2013)

A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
por: Priya, Gagan, et al.
Publicado: (2017)

Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
por: Yadegarfar, Ghasem, et al.
Publicado: (2021)

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
por: Bruijnzeel, Dawn, et al.
Publicado: (2016)

Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
por: Karras, Spyridon N, et al.
Publicado: (2019)

Effects of Antioxidant in Adjunct with Periodontal Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Mizutani, Koji, et al.
Publicado: (2021)

Periodontal therapy as an adjunctive modality for HbA1c reduction in type-2 diabetic patients
por: Sundar, Chalini, et al.
Publicado: (2018)

Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes
por: Shukla, Rishi, et al.
Publicado: (2021)

Effectiveness of acupuncture as adjunctive therapy in type 2 diabetic: Study protocol for a randomized controlled trial
por: Cheok, Yean Chin, et al.
Publicado: (2023)

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes
por: Tauschmann, Martin, et al.
Publicado: (2017)

Sodium‐glucose co‐transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction
por: Tiwary, Mansi, et al.
Publicado: (2022)

Aptamer Technology: Adjunct Therapy for Malaria
por: Nik Kamarudin, Nik Abdul Aziz, et al.
Publicado: (2017)

Exploring Mucin as Adjunct to Phage Therapy
por: Carroll-Portillo, Amanda, et al.
Publicado: (2021)

Considerations for and Mechanisms of Adjunct Therapy in COPD
por: Mandru, Rachana, et al.
Publicado: (2021)

Adjunctive Nutraceutical Therapies for COVID-19
por: Subedi, Lalita, et al.
Publicado: (2021)

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)

Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes
por: Christiaens, Antoine, et al.
Publicado: (2020)

Patient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus
por: Tran, Mongthuong T., et al.
Publicado: (2008)

Adjunctive therapy in Parkinson’s disease: the role of rasagiline
por: Gaines, Kathryn D, et al.
Publicado: (2012)

Glutathione Supplementation as an Adjunctive Therapy in COVID-19
por: Guloyan, Vika, et al.
Publicado: (2020)

Review of Under-Recognized Adjunctive Therapies for Cancer
por: Money, Mary E., et al.
Publicado: (2022)

The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use
por: Price, David, et al.
Publicado: (2016)

Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes
por: Rabinovitch, Alexander, et al.
Publicado: (2023)

Glucose control in type 1 diabetes and COVID-19
por: Mungmunpuntipantip, R., et al.
Publicado: (2021)

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
por: El-Batarny, Ashraf M
Publicado: (2008)

Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocol
por: Laugesen, Christian, et al.
Publicado: (2020)

A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control
por: Wolkowicz, Kelilah L., et al.
Publicado: (2020)

Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
por: Ho, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9egm9ba6lchn705pcb7gbtfl0